Factors influencing the need for target vessel revascularization after renal artery stenting

Journal of Endovascular Therapy

Volumn 13, Issue 5, 2006, Pages 569-577

  Bates, Mark C ^a,b,d   Rashid, Mitchell ^c   Campbell, John E ^b   Stone, Patrick A ^b   Broce, Mike ^a   Lavigne, Philip S ^a  

^a CHARLESTON AREA MEDICAL CENTER   (United States)

^b West Virginia University School of Medicine Charleston   (United States)

^c MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Charleston Area Medical Center Research Institute ^*  (United States)

Author keywords

Angioplasty; Atherosclerosis; Outcome analysis; Renal artery; Restenosis; Stent

Indexed keywords

HEPARIN;

ADULT; AGED; ANGIOPLASTY; ATHEROSCLEROSIS; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; KAPLAN MEIER METHOD; KIDNEY ARTERY STENOSIS; KIDNEY FAILURE; LONGITUDINAL STUDY; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RESTENOSIS; RETROSPECTIVE STUDY; REVASCULARIZATION; REVIEW; RISK FACTOR; SOLITARY KIDNEY; STATISTICAL ANALYSIS; STENT; STROKE; UREA NITROGEN BLOOD LEVEL; UREMIA;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANGIOPLASTY, BALLOON; BLOOD VESSEL PROSTHESIS IMPLANTATION; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; FOLLOW-UP STUDIES; GRAFT OCCLUSION, VASCULAR; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; RENAL ARTERY OBSTRUCTION; REOPERATION; RETROSPECTIVE STUDIES; STENTS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 33750977255     PISSN: 15266028     EISSN: None     Source Type: Journal    
DOI: 10.1583/06-1861.1     Document Type: Review

References (48)

1. Goldblatt H, Lynch J, Hanzal RF, et al. Studies on experimental hypertension; production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exper Med. 1934;59:347-349.
2. Gruntzig A, Kuhlmann U, Vetter W, et al. Treatment of renovascular hypertension with percutaneous transluminal dilatation of a renal-artery stenosis. Lancet. 1978;1:801-802.
3. Wollenweber J, Sheps SG, David DG. Clinical course of atherosclerotic renovascular disease. Am J Cardiol. 1968;21:60-71.
4. Stewart BH, Dustan HP, Kiser WS, et al. Correlation of angiography and natural history in evaluation of patients with renovascular hypertension. J Urol. 1970;104:231-238.
5. Dean RH, Keiffer RW, Smith BW, et al. Renovascular hypertension: anatomic and renal function changes during therapy. Arch Surg. 1981;116:1408-1415.
6. Schreiber MJ, Pohl MA, Novick AC. The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am. 1984;11:383-392.
7. Caps MT, Zierler RE, Polissar NL, et al. Risk of atrophy in kidneys with atherosclerotic renal artery stenosis. Kidney Int. 1998;53:735-742.
8. Tollefson DE, Ernest CB. Natural history of atherosclerotic renal artery stenosis associated with aortic disease. J Vasc Surg. 1991;14:327-331.
9. Zierler RE, Bergelin RO, Isaacson JA, et al. Natural history of renal artery stenosis: a prospective study with duplex ultrasound. J Vasc Surg. 1994;19:250-258.
10. Strandness DE. Natural history of renal artery stenosis. Am J Kid Dis. 1994;24:630-635.
11. Sos TA, Pickering TG, Saddekni S, et al. The current role of renal angioplasty in the treatment of renovascular hypertension. Urol Clin North Am. 1984;11:503-513.
12. Martin LG, Cork RD, Kaufman SL. Long-term results of angioplasty in 110 patients with renal artery stenosis. J Vasc Interv Radiol. 1992;3: 619-626.
13. Plouin PF, Darne B, Chatellier G. Restenosis after a first percutaneous transluminal renal angioplasty. Hypertension. 1993;21:89-96.
14. Dean RH, Callis JT, Smith BM, et al. Failed percutaneous transluminal renal angioplasty: experience with lesions requiring operative intervention. J Vasc Surg. 1987;6:301-307.
15. Joffre F, Rousseau H, Bernadet P, et al. Midterm results of renal artery stenting. Cardiovasc Intervent Radiol. 1992;15:313-318.
16. Dorros G, Prince C, Mathiak L. Stenting of a renal artery stenosis achieves better relief of the obstructive lesion than balloon angioplasty. Cathet Cardiovasc Diagn. 1993;29:191-198.
17. Dorros G, Jaff M, Mathiak L, et al. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation. 1998;98:642-647.
18. Boisclair C, Therasse E, Oliva VL, et al. Treatment of renal angioplasty failure by percutaneous renal artery stenting with Palmaz stents: midterm technical and clinical results. AJR Am J Roentgenol. 1997;168:245-251.
19. Blum U, Krumme B, Flugel P, et al. Treatment of ostial renal artery stenoses with vascular endoprostheses after unsuccessful balloon angioplasty. N Engl J Med. 1997;336:459-465.
20. Bredenberg CD, Sampson LN, Ray FS, et al. Changing patterns in surgery for chronic renal artery occlusive diseases. J Vasc Surg. 1992; 15:1018-1024.
21. Hansen KJ, Starr SM, Sands RE, et al. Contemporary surgical management of renovascular disease. J Vasc Surg. 1992;16:319-331.
22. Cambria RP, Brewster DC, L'Italien GJ, et al. The durability of different reconstructive techniques for atherosclerotic renal artery disease. J Vasc Surg. 1994;20:76-87.
23. Taylor A, Sheppard D, Macleod MJ, et al. Renal artery stent placement in renal artery stenosis: technical and early clinical results. Clin Radiol. 1997;52:451-457.
24. Henry M, Amor M, Henry IE, et al. Stents in the treatment of renal artery stenosis: long-term follow-up. J Endovasc Surg. 1999;6:42-51.
25. Equine O, Beregi JP, Mounier-Vehier C, et al. Anatomic results of the endoluminal revascularization of renal arterial stenoses. A retrospective study of 113 patients [in French]. Arch Mal Coeur Vaiss. 1999;92:1009-1013.
26. Yutan E, Glickerman DJ, Caps MT, et al. Percutaneous transluminal revascularization for renal artery stenosis: Veterans Affairs Puget Sound Health Care System experience. J Vasc Surg. 2001;34:685-693.
27. Perkovic V, Thomson KR, Mitchell PJ, et al. Treatment of renovascular disease with percutaneous stent insertion: long-term outcomes. Australes Radiol. 2001;45:438-443.
28. Zeller T, Frank U, Muller C, et al. Predictors of improved renal function after percutaneous stent-supported angioplasty of severe atherosclerotic ostial renal artery stenosis. Circulation. 2003;108:2244-2249.
29. Bucek RA, Puchner S, Reiter M, et al. Long-term follow-up after renal artery stenting. Wien Klin Wochenschr. 2003;115:788-792.
30. Feldman RL, Wargovich TJ, Bittl JA. No-touch technique for reducing aortic wall trauma during renal artery stenting. Cathet and Cardio Int. 1999;46:245-248.
31. Rundback JH, Sacks D, Kent KC, et al. Guidelines for the reporting of renal artery revascularization in clinical trials. American Heart Association. Circulation. 2002;106:1572-1585.
32. Bakker J, Goffette PP, Henry M, et al. The Erasme study: a multicenter study on the safety and technical results of the Palmaz stent used for the treatment of atherosclerotic ostial renal artery stenosis. Cardiovasc Intervent Radiol. 1999;22:468-474.
33. Lederman RJ, Mendelsohn FO, Santos R, et al. Primary renal artery stenting: characteristics and outcomes after 363 procedures. Am Heart J. 2001;142:314-323.
34. Zeller T, Muller C, Frank U, et al. Gold coating and restenosis after primary stenting of ostial renal artery stenosis. Catheter Cardiovasc Interv. 2003;60:1-8.
35. Shammas NW, Kapalis MJ, Dippel EJ, et al. Clinical and angiographic predictors of restenosis following renal artery stenting. J Invasive Cardiol. 2004;16:10-13.
36. Vignali C, Bargellini I, Lazzereschi M, et al. Predictive factors of in-stent restenosis in renal artery stenting: a retrospective analysis. Cardiovasc Intervent Radiol. 2005;28:296-302.
37. Iannone LA, Underwood PL, Nath A, et al. Effect of primary balloon expandable renal artery stents on long-term patency, renal function, and blood pressure in hypertensive and renal insufficient patients with renal artery stenosis. Cathet Cardiovasc Diagn. 1996;37:243-250.
38. White CJ, Ramee SR, Collins TJ, et al. Renal artery stent placement: utility in lesions difficult to treat with balloon angioplasty. J Am Coll Cardiol. 1997;30:1445-1450.
39. Dorros G, Jaff M, Jain A, et al. Follow-up of primary Palmaz-Schatz stent placement for atherosclerotic renal artery stenosis. Am J Cardiol. 1995;75:1051-1055.
40. Zeller T, Muller C, Frank U, et al. Survival after stenting of severe atherosclerotic ostial renal artery stenoses. J Endovasc Ther. 2003;10:539-545.
41. Ramos F, Kotliar C, Alvarez D, et al. Renal function and outcome of PTRA and stenting for atherosclerotic renal artery stenosis. Kidney Int. 2003;63:276-282.
42. Rocha-Singh KJ, Ahuja RK, Sung CH, et al. Long-term renal function preservation after renal artery stenting in patients with progressive ischemic nephropathy. Catheter Cardiovasc Interv. 2002;57:135-141.
43. Zeller T, Frank U, Muller C, et al. Stent-supported angioplasty of severe atherosclerotic renal artery stenosis preserves renal function and improves blood pressure control: long-term results from a prospective registry of 456 lesions. J Endovasc Ther. 2004;11:95-106.
44. Burket MW, Cooper CJ, Kennedy DJ, et al. Renal artery angioplasty and stent placement: predictors of a favorable outcome. Am Heart J. 2000;139:64-71.
45. Zeller T, Rastan A, Kliem M, et al. Impact of carbon coating on the restenosis rate after stenting of atherosclerotic renal artery stenosis. J Endovasc Ther. 2005;12:605-611.
46. Cioni R, Vignali C, Petruzzi P, et al. Renal artery stenting in patients with a solitary functioning kidney. Cardiovasc Intervent Radiol. 2001;24: 372-377.
47. Shannon HM, Gillespie IN, Moss JG. Salvage of the solitary kidney by insertion of a renal artery stent. AJR Am J Roentgenol. 1998;171: 217-222.
48. Bush RL, Martin LG, Lin PH, et al. Endovascular revascularization of renal artery stenosis in the solitary functioning kidney. Ann Vasc Surg. 2001;15:60-66.